Lagan, Briege M, Dolk, Helen, Sinclair, M. and White, Bronagh (2012) Online Purchasing of Isotretinoin: E-Pharmacies Provision of Safety Information. Pharmacoepidemiology and Drug Safety, 21 ((Supp ). pp. 1-481. [Journal article]
- Accepted Version
Indefinitely restricted to Repository staff only.
Background: The purpose of Isotretinoin Pregnancy Prevention Programs (PPP) is to utilise a variety of approaches and strategies to control the prescription of, and diminish the risks of women of child bearing age receiving this medication during pregnancy. With thegrowing phenomenon of online pharmacies, consumers are now able to purchase Isotretinoin online without the requisite safety procedures.Objectives: A structured survey of e-pharmacies selling Isotretinoin to evaluate what safety measures and regulations are in place for women of child bearing age.Methods: The terms ‘‘buy’’ and ‘‘Isotretinoin’’ was entered into five commonly used search engines. Ten different online pharmacies URL’s (Uniform Resource Locator) from each search engine, all selling isotretinoin, were stored for evaluation. The safety information content of each of the 50 sites was evaluated independently for accuracy and completeness by two raters using criteria derived from the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare Regulatory Agency (MHRA) for dispensing Isotretinoin to women at risk of pregnancy.Results: Eight (16%) of the websites made no reference to the use of Isotretinoin in pregnancy. Information provided by 35 (70%) of the websites was of poor or very poorquality in relation to the need for and recommended methods for pregnancy prevention. Misleading statements were recorded on several of the websites. Isotretinoincould be readily purchased from 42 (84%) of the sites without a valid prescription.Conclusions: Women of child bearing age have the option to self-purchase Isotretinoin directly from web sites that do not provide any form of risk assessment, pregnancyprevention education, or warnings of the dangers associated with taking this medication. These findings have implications for the design of Pregnancy Prevention Programmes,for clinicians, and for legal regulation of internet pharmacies.
|Item Type:||Journal article|
|Faculties and Schools:||Faculty of Life and Health Sciences > School of Pharmacy and Pharmaceutical Science|
Faculty of Life and Health Sciences > School of Nursing
Faculty of Life and Health Sciences
|Research Institutes and Groups:||Institute of Nursing and Health Research|
Biomedical Sciences Research Institute
Institute of Nursing and Health Research > Centre for Maternal, Fetal and Infant Research
Biomedical Sciences Research Institute > Pharmaceutical Science and Practice
|Deposited By:||Dr Briege M Lagan|
|Deposited On:||24 Sep 2012 08:48|
|Last Modified:||04 Dec 2012 14:36|
Repository Staff Only: item control page